Daniel Kuritzkes

Multidisciplinary HIV Training Program

National Institute of Allergy and Infectious Diseases · T32

Contact PI · $5.2M · Brigham and Women's Hospital

A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana

National Institute of Allergy and Infectious Diseases · U01

PI · $8.2M · Harvard University d/b/a Harvard School of Public Health

Boston HIV CTU

National Institute of Allergy and Infectious Diseases · UM1

Contact PI · $55M · Brigham and Women's Hospital

A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibody VRC01 on HIV Viral Reservoir and Maintenance of Suppression in a Cohort of Early-Treated Children in Botswana

National Institute of Allergy and Infectious Diseases · U01

PI · $10.4M · The Botswana Harvard Health Partnership

Dual bNAb Treatment in Children

Principal investigator · Completed · Phase 1, Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Principal investigator · Completed · Phase 1, Phase 2

Massachusetts General Hospital

Early Infant HIV Treatment in Botswana

Principal investigator · Active not recruiting · Phase 2, Phase 3

Harvard School of Public Health (HSPH)

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

Principal investigator · Terminated

Brigham and Women's Hospital